In another androgen-independent prostate cancer CL1 cell line, 1 μM of SH122 was sufficient to pull down both XIAP and cIAP-1 (Figure 1C), and as with DU145, the binding effect was blocked by a 10-fold excess of non-labeled SH122. Here, XIAP is linked to prostate cancer.